相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Nathalie L. Albert et al.
NEURO-ONCOLOGY (2016)
Diffusion and Perfusion MRI to Differentiate Treatment-Related Changes Including Pseudoprogression from Recurrent Tumors in High-Grade Gliomas with Histopathologic Evidence
A. J. Prager et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Hideho Okada et al.
LANCET ONCOLOGY (2015)
Pitfalls in le neuroimaging of glioblastoma in le era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response
Raymond Y. Huang et al.
FRONTIERS IN NEUROLOGY (2015)
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET
Norbert Galldiks et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Emerging Applications for Ferumoxytol as a Contrast Agent in MRI
Mustafa R. Bashir et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2015)
Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence
Alexander Radbruch et al.
NEURO-ONCOLOGY (2015)
The Diagnosis and Treatment of Pseudoprogression, Radiation Necrosis and Brain Tumor Recurrence
Kashif Parvez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients
Ken Herrmann et al.
NEURO-ONCOLOGY (2014)
MRI perfusion in determining pseudoprogression in patients with glioblastoma
Robert J. Young et al.
CLINICAL IMAGING (2013)
Defining pseudoprogression in glioblastoma multiforme
E. Van Mieghem et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Treatment-Related Change Versus Tumor Recurrence in High-Grade Gliomas: A Diagnostic Conundrum-Use of Dynamic Susceptibility Contrast-Enhanced (DSC) Perfusion MRI
Girish M. Fatterpekar et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2012)
The Concepts, Diagnosis and Management of Early Imaging Changes after Therapy for Glioblastomas
P. Sanghera et al.
CLINICAL ONCOLOGY (2012)
Late and Prolonged Pseudoprogression in Glioblastoma After Treatment With Lomustine and Temozolomide
Moritz Stuplich et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Use of 11C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma Clinical article
Yasuyoshi Chiba et al.
JOURNAL OF NEUROSURGERY (2012)
Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
MR perfusion and diffusion imaging in the follow-up of recurrent glioblastoma treated with dendritic cell immunotherapy: a pilot study
Matej Vrabec et al.
NEURORADIOLOGY (2011)
Vaccine provides new hope for patients with deadly brain cancer
[Anonymous]
FUTURE NEUROLOGY (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Validation of Functional Diffusion Maps (fDMs) as a Biomarker for Human Glioma Cellularity
Benjamin M. Ellingson et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2010)
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
John H. Sampson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements
L. S. Hu et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2009)
Distinguishing Recurrent Intra-Axial Metastatic Tumor from Radiation Necrosis Following Gamma Knife Radiosurgery Using Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging
R. F. Barajas et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2009)
Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression
Elizabeth R. Gerstner et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence
Friso W. A. Hoefnagels et al.
JOURNAL OF NEUROLOGY (2009)
Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging
Ramon F. Barajas et al.
RADIOLOGY (2009)
Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide
Walter Taal et al.
CANCER (2008)
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
Alba A. Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
PET Imaging of cancer immunotherapy
Paul C. Tunieh et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy
Yuzo Terakawa et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Dieto Brandsma et al.
LANCET ONCOLOGY (2008)
Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology
Alba A. Brandes et al.
NEURO-ONCOLOGY (2008)
Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging
Qing-Shi Zeng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy
Marc C. Chamberlain
NEUROLOGY (2006)
Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions
Pia C. Sundgren et al.
MAGNETIC RESONANCE IMAGING (2006)
Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme
L. Stenberg et al.
ACTA RADIOLOGICA (2006)
MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy
WB Pope et al.
NEUROLOGY (2006)
Positron emission tomography with O-(2-[18F]fluoroethyl)-L-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas
W Rachinger et al.
NEUROSURGERY (2005)
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression
MCY de Wit et al.
NEUROLOGY (2004)
Value of O-(2-[18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma
G Pöpperl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis
JP Rock et al.
NEUROSURGERY (2004)
99mTc-MIBI and 201Tl SPET in the detection of recurrent brain tumours after radiation therapy
Y Yamamoto et al.
NUCLEAR MEDICINE COMMUNICATIONS (2002)
Role of angiogenesis in tumor growth and metastasis
J Folkman
SEMINARS IN ONCOLOGY (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
